Product image of Levofloxacin Fresenius Kabi (Levofloxacin) supplied by GNH India

Levofloxacin Fresenius Kabi

Active Ingredient:
Levofloxacin
Origin:
EU

Levofloxacin Fresenius Kabi (Levofloxacin)

Levofloxacin, the active ingredient in Levofloxacin Fresenius Kabi, is a fluoroquinolone antibiotic presented as an injectable solution for intravenous use. It is employed to treat a broad spectrum of serious bacterial infections in adult patients, including respiratory, urinary, and soft‑tissue infections. The drug is indicated for both community‑acquired and hospital‑acquired infections, providing clinicians with a potent option when oral therapy is unsuitable.

GNH India supplies Levofloxacin Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics that require reliable intravenous antibiotic solutions worldwide.

Manufacturer / TM Owner

Fresenius Kabi Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levofloxacin is a fluoroquinolone antibiotic used to treat bacterial infections affecting various organ systems.
  • Community‑acquired pneumonia: rapid bacterial clearance leading to clinical improvement.
  • Hospital‑acquired pneumonia: eradication of resistant Gram‑negative pathogens.
  • Complicated urinary tract infections: resolution of infection and prevention of recurrence.
  • Skin and soft tissue infections: reduction of cellulitis and wound infection signs.
  • Intra‑abdominal infections: control of polymicrobial abdominal sepsis.
  • Prostatitis: elimination of causative organisms and symptom relief.

How It Works

  • Levofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes essential for DNA supercoiling and replication. By binding to the enzyme‑DNA complex, it prevents unwinding and resealing of DNA strands, halting bacterial DNA synthesis and transcription, which results in bactericidal activity against susceptible Gram‑negative and Gram‑positive organisms.

Side Effects

Levofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Diarrhea: loose stools, usually self‑limiting.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional vertiginous sensation.

Serious or Rare Side Effects

  • Tendon rupture: especially Achilles, may occur without warning.
  • QT interval prolongation: risk of cardiac arrhythmias.
  • Clostridioides difficile infection: severe colitis requiring medical attention.

Precautions & Warnings

  • When prescribing Levofloxacin, clinicians should consider several safety precautions.
  • Renal impairment: adjust dose based on renal function.
  • History of tendon disorders: avoid use due to risk of tendon rupture.
  • QT prolongation risk: monitor ECG in patients with cardiac arrhythmias.
  • Concurrent use with antacids or multivitamins: separate administration by at least 2 hours.
  • Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Levofloxacin can interact with other medicines, altering effectiveness or increasing toxicity.

Major Interactions (Avoid)

  • Other fluoroquinolones (e.g., ciprofloxacin): additive toxicity; avoid concurrent use.
  • Warfarin: increased anticoagulant effect; monitor INR closely.
  • Theophylline: increased plasma levels; risk of seizures.

Moderate Interactions (Monitor Closely)

  • Antacids containing aluminum or magnesium: reduce levofloxacin absorption; separate dosing.
  • NSAIDs: may increase risk of central nervous system stimulation.
  • Diabetes medications (insulin, sulfonylureas): may cause hypoglycemia; monitor glucose levels.

Frequently Asked Questions

Levofloxacin Fresenius Kabi is an intravenous fluoroquinolone antibiotic indicated for the treatment of serious bacterial infections such as community‑acquired and hospital‑acquired pneumonia, complicated urinary tract infections, skin and soft‑tissue infections, intra‑abdominal infections, and prostatitis.

Levofloxacin works by binding to bacterial DNA gyrase and topoisomerase IV, enzymes that control DNA supercoiling and replication. This binding blocks DNA unwinding and resealing, halting bacterial DNA synthesis and transcription, which leads to rapid bacterial cell death.

The specific dose and duration of Levofloxacin Fresenius Kabi are determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function, and local antimicrobial guidelines. No fixed regimen is provided here.

Safety data for levofloxacin in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Clinicians should weigh potential benefits against risks and discuss options with the patient before use.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Levofloxacin offers broad‑spectrum activity against both Gram‑negative and Gram‑positive bacteria and can be administered intravenously, providing rapid serum concentrations. Compared with older fluoroquinolones, it has improved pharmacokinetics and a lower risk of certain drug‑resistance mechanisms, but safety considerations such as tendon toxicity remain similar across the class.

Levofloxacin Fresenius Kabi must be stored at 2‑8 °C (refrigerated). Keep the vials in the original packaging, protect them from light, and do not freeze or shake the solution before use.

The product is supplied as a sterile injectable solution for intravenous infusion. It is typically diluted in an appropriate compatible fluid and administered over a period defined by the prescriber, often as a short infusion or continuous drip depending on the clinical scenario.

Serious adverse events include tendon rupture (especially Achilles), QT interval prolongation leading to arrhythmias, and Clostridioides difficile‑associated colitis. Patients should be educated to report sudden tendon pain, palpitations, or severe diarrhea promptly.

Levofloxacin is contraindicated in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, and patients with significant QT prolongation or uncontrolled cardiac arrhythmias.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.